AI-generated from publicly available materials.This week’s updates in European HealthTech highlight significant trends in funding, regulatory changes, and advancements in clinical AI technologies.
Venture capital is increasingly focusing on clinical backend operations and interoperability within healthcare systems. Notable funding rounds in the UK and Nordic regions are supporting tools designed to enhance care orchestration and reduce provider burnout, particularly through improved integration of electronic health records (EHRs). This shift suggests a growing recognition of the need for streamlined operational efficiency in healthcare delivery.
Health systems are favoring domain-specific AI models over general-purpose large language models (LLMs). For instance, Danish firm Corti has shown that specialized clinical coding can outperform broader models in diagnostic accuracy. This trend indicates a potential pivot towards more tailored AI solutions that can better meet the unique demands of healthcare environments in Europe.
On the regulatory front, the MedTech sector is advocating for revisions to the EU's AI Act and Medical Devices Regulation (MDR). There is a push for regulatory sandboxes that allow for real-world testing of AI models, aiming to prevent innovation from migrating to regions with more favorable regulations. Additionally, various European countries are enhancing their digital health reimbursement frameworks, which could pave the way for broader acceptance and integration of digital therapeutics.
As these developments unfold, the emphasis on risk-adaptive surveillance and the establishment of cross-border genomic data infrastructures are likely to play crucial roles in shaping the future landscape of healthcare technology in Europe. The ongoing evolution of procurement strategies, focusing on total cost of care rather than just purchase price, further underscores a shift towards value-based healthcare solutions.